Britannica Sources used in this answer

How are neural stem cells being studied for Parkinson disease and spinal cord injuries?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

Diagram showing the locations of neural stem cells in brain regions such as the hippocampus and ventricles, and hematopoietic stem cells in the bone marrow and blood, with labeled illustrations of the brain, spinal cord, circulatory system, and skeleton. — stem cell Stem cells of neural and hematopoietic origin have tremendous potential in the development of therapies for certain diseases, such as diabetes and Parkinson disease. Neural stem cells occur in the spinal cord and in specific regions of the brain, and hematopoietic stem cells occur in the blood and bone marrow.

Research into neural stem cells (NSCs) and embryonic stem cells (ESCs) offers potential therapeutic avenues for Parkinson disease and spinal cord injuries, though significant challenges remain.

Parkinson Disease

In Parkinson disease, the loss of dopaminergic neurons is a primary concern. Research focuses on:
* Cell Transplantation: Scientists are investigating the use of ESCs to generate dopaminergic neurons for transplantation into the striata of patients.12
* Overcoming Obstacles: Current research aims to improve the survival of transplanted progenitor cells, ensure the purity of cell populations, and address the long differentiation times required for human ESCs.1

Spinal Cord Injuries

For spinal cord injuries, studies explore both endogenous and exogenous approaches:
* Exogenous Therapy: Researchers have tested the transplantation of stem cells, including oligodendrocyte progenitors derived from ESCs, to restore nerve function. One notable clinical trial (GRNOPC1) aimed to use these progenitors to mature into oligodendrocytes, which are essential for supporting nerve signaling.12
* Endogenous Stimulation: Scientists are investigating ways to stimulate the body's own dormant NSCs within the spinal cord to promote repair.1

While these therapies hold promise, researchers must still master the control of cell proliferation, migration, and integration into existing neuronal networks to ensure safety and efficacy.1